Kö'ln, Germany

Marcus Karlstetter

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Marcus Karlstetter in Neurodegenerative Disease Treatment.

Introduction

Marcus Karlstetter is a notable inventor based in Kö'ln, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative and neuroinflammatory diseases. His work focuses on the development of polysialic acid and its applications in therapeutic settings.

Latest Patents

Marcus Karlstetter holds a patent for "Polysialic acid and use for treatment of neurodegenerative and neuroinflammatory diseases." This invention relates to a branched or unbranched free or glycosidically bound polysialic acid according to the general formula (1). The formula is represented as poly-(α(2→8 or 2→9)Neu5Ac)(1), where Neu5Ac is N-acetylneuraminic acid, and n is an integer in the range from 14 to 26. The patent also includes pharmaceutically acceptable salts of the polysialic acid, a polysaccharide composition comprising the polysialic acid, and its use as a medicament. This invention is particularly relevant for the therapeutic and prophylactic treatment of degenerative, demyelinating, and inflammatory diseases of the central nervous system, as well as degenerative or inflammatory retinal diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Marcus Karlstetter has worked at prestigious institutions such as Rheinische Friedrich-Wilhelms-Universität Bonn and Universität zu Köln. His research has focused on innovative solutions to complex medical challenges, particularly in the realm of neurodegenerative diseases.

Collaborations

Some of his notable coworkers include Harald Neumann and Jens Kopatz. Their collaborative efforts have contributed to advancing research in the field of neuroinflammation and neurodegeneration.

Conclusion

Marcus Karlstetter's innovative work in polysialic acid has the potential to significantly impact the treatment of neurodegenerative diseases. His contributions to medical science highlight the importance of research and innovation in addressing complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…